AI assistant
IMMUNIC, INC. — Director's Dealing 2015
Sep 16, 2015
10196_dirs_2015-09-16_06f870cb-86e5-4e9b-9150-87b66cd22490.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2015-09-14
Reporting Person: Winters Terence E. (Director, Co-Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-14 | Common Stock | M | 128394 | $0.4284 | Acquired | 190566 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-14 | Stock Option (right to buy) | $0.4284 | M | 128394 | Disposed | 2022-04-01 | Common Stock (128394) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 119964 | Indirect |
Footnotes
F1: Excludes 119,964 shares previously owned directly by the reporting person which were contributed to the Winters Family Trust on February 13, 2015.
F2: This stock option was granted on April 1, 2012 and vests over four years. Subject to the reporting person continuing to provide services, one forty-eighth of the shares subject to the option vest one month after the vesting commencement date of February 8, 2012, and an additional one forty-eighth of the shares vest at the end of each monthly period thereafter. The option is subject to an early exercise provision and is immediately exercisable.